Mark P. Colonnese, Chief Financial Officer at Biota Pharmaceuticals, Inc. (BOTA), bought 7,000 shares at $1.41 ($10K) on 2016-02-09, disclosed to the SEC on 2016-02-09.
Open-market purchase of $10k BOTA by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.40 | 300 | $420 | 4.3% |
| 2 | $1.41 | 6,700 | $9K | 95.7% |
| Total | $1.41 avg | 7,000 | $10K | 100% |